BCLSI
EQRX

Bain Capital Life Sciences Investors’s EQRx, Inc. Common Stock EQRX Stock Holding History

Bain Capital Life Sciences Investors’s Portfolio EQRX Stock Details EQRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,003,573
Closed -$22.2M – 33
2023
Q3 		$22.2M Hold
10,003,573
– – 2.48% 12
2023
Q2 		$18.6M Hold
10,003,573
– – 1.92% 17
2023
Q1 		$19.4M Hold
10,003,573
– – 2.43% 15
2022
Q4 		$24.6M Hold
10,003,573
– – 2.75% 13
2022
Q3 		$49.5M Hold
10,003,573
– – 5.91% 6
2022
Q2 		$46.9M Hold
10,003,573
– – 5.5% 5
2022
Q1 		$41.3M Hold
10,003,573
– – 4.01% 8
2021
Q4 		$68.2M Buy
+10,003,573
New +$94.4M 5.41% 5

Bain Capital Life Sciences Investors's EQRX Position: Q4 2023 in Review

Bain Capital Life Sciences Investors sold out of EQRx, Inc. Common Stock (EQRX) in Q4 2023, closing a stake of 10,003,573 shares — an estimated $22.2M sold.

Bain Capital Life Sciences Investors first reported a position in EQRX in Q4 2021 and held it in 8 quarters. The position peaked at $68.2M in Q4 2021. 0 funds tracked by Wall St. Rank hold EQRX as of Q4 2023.

  • Bain Capital Life Sciences Investors reported no remaining EQRx, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Bain Capital Life Sciences Investors sold 10,003,573 EQRx, Inc. Common Stock shares in Q4 2023, an estimated $22.2M.
  • Bain Capital Life Sciences Investors first reported a position in EQRx, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Bain Capital Life Sciences Investors's EQRx, Inc. Common Stock position peaked at $68.2M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held EQRx, Inc. Common Stock as of Q4 2023.

Based on Bain Capital Life Sciences Investors's 13F filing for Q4 2023, filed 13 Feb 2024.